"The Biotech Death of Jesse Gelsinger"
Newspaper article
By: Sheryl Gay Stohlberg
Date: November 28, 1999
Source: Stohlberg, Sheryl Gay. "The Biotech Death of Jesse Gelsinger." The New York Times, November 28, 1999. Reprinted in Cohen, Jesse, ed. The Best American Science Writing 2000. New York: HarperCollins, 2000, 45–56.
Introduction
After the first gene therapy treatment occurred in 1990, there was immense hope that it could miraculously cure hundreds of inherited metabolic disorders. It seemed so simple: replace the defective gene with a functional gene—the disorder is cured. Gene therapy had given many people suffering from such metabolic diseases as ornithine transcarbamylase (OTC) the best reason to hope for a cure than they had ever had. In the late 1990s, when Jesse Gelsinger volunteered, several gene therapy trials were occurring across the country. However, no one had yet been cured by...
[The entire page is 6101 words long]
1990's Medicine and Health Primary Sources
The 1990's: Primary Sources
